((自动化翻译由路透提供，请见免责声明 ))
10月22日 - ** 癌症疗法生产商联想生物 股价盘前上涨约8%，报46.80美元
** 生命科学公司Genscript 周二表示，该公司的主要股东Genscript 董事会已 "决定不再合并联想集团"。
** Genscript 表示，在取消合并后，它将采用权益法核算其在 LEGN 的投资
** Genscript 预计将确认与撤消合并相关的一次性收益
** 截至 2023 年 12 月 31 日，Genscript 拥有约 1.745 亿股 LEGN 股份
** 截至上次收盘，LEGN 年内下跌约 28
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.